dc.contributor.author | Brekke, Kurt Richard | |
dc.contributor.author | Straume, Odd Rune | |
dc.contributor.author | Holmås, Tor Helge | |
dc.date.accessioned | 2010-10-19T11:48:17Z | |
dc.date.available | 2010-10-19T11:48:17Z | |
dc.date.issued | 2010-07 | |
dc.identifier.issn | 0804-6824 | |
dc.identifier.uri | http://hdl.handle.net/11250/163262 | |
dc.description.abstract | We study the impact of product margins on pharmacies incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead.
We show that pharmacies substitution incentives are determined by relative margins and relative patient copayments. Second, we exploit a unique product level panel data set, which contains information on sales and prices at both producer and retail level. In the empirical analysis, we find a strong relationship between the margins of brand-names and generics and their market shares. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales. | en |
dc.language.iso | eng | en |
dc.publisher | Norwegian School of Economics and Business Administration. Department of Economics | en |
dc.relation.ispartofseries | Discussion paper | en |
dc.relation.ispartofseries | 2010:18 | en |
dc.subject | pharmaceuticals | en |
dc.subject | pharmacies | en |
dc.subject | generic substitution | en |
dc.title | Margins and market shares : pharmacy incentives for generic substitution | en |
dc.type | Working paper | en |
dc.subject.nsi | VDP::Samfunnsvitenskap: 200::Økonomi: 210 | en |